Tau protein binds to the P53 E3 ubiquitin ligase MDM2

Sci Rep. 2023 Jun 23;13(1):10208. doi: 10.1038/s41598-023-37046-8.

Abstract

Tau gene mutations cause a progressive dementia and neurotoxic Tau forms deposited in neurofibrillary tangles are hallmarks of neurodegenerative tauopathies. Loss of non-canonical Tau functions may contribute to disease. In fact, Tau depletion affects the cellular response to DNA damage and tauopathies exhibit the accumulation of DNA lesions. Moreover, Tau modulates P53 activity and cell fate. Considering that MDM2 is the main antagonist of P53, we investigated, using orthogonal assays, if Tau interacts with MDM2. We report the existence in cells and brain of a Tau-MDM2 complex that, in vitro, exhibits reduced P53 ubiquitination activity in a manner sensitive to a Tau mutation. The Tau-MDM2 interaction involves the microtubule-binding domain of Tau and the acidic domain of MDM2, reminiscent of the binding of Tau to negatively charged microtubules. Notably, MDM2 accumulates aberrantly in neurofibrillary tangles. Aging-associated insults may expose a novel loss-of-function of Tau in neurodegeneration and cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Protein Binding
  • Proto-Oncogene Proteins c-mdm2 / genetics
  • Proto-Oncogene Proteins c-mdm2 / metabolism
  • Tauopathies*
  • Tumor Suppressor Protein p53 / metabolism
  • Ubiquitin-Protein Ligases* / metabolism
  • Ubiquitination
  • tau Proteins / genetics
  • tau Proteins / metabolism

Substances

  • Ubiquitin-Protein Ligases
  • Proto-Oncogene Proteins c-mdm2
  • Tumor Suppressor Protein p53
  • tau Proteins
  • MDM2 protein, human